Quality of Life and Pain Changes Due to DRG Stimulation for Chronic Pain
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Chronic Pain, Orthopedic, Psychiatric, Women's Studies, Pain |
| Therapuetic Areas: | Musculoskeletal, Psychiatry / Psychology, Orthopedics / Podiatry, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 2/2/2018 |
| Start Date: | August 1, 2017 |
| End Date: | December 31, 2020 |
A Prospective Single-arm, Multi-center Clinical Study Examining Quality of Life and Pain Following Dorsal Root Ganglion Stimulation for the Treatment of Chronic Intractable Pelvic and Lower Limb Pain
ACTIVE study- a prospective observational clinical study examining the changes in quality of
life and pain following dorsal root ganglion stimulation for the treatment of chronic
intractable pelvic and lower limb pain.
life and pain following dorsal root ganglion stimulation for the treatment of chronic
intractable pelvic and lower limb pain.
Objectives The primary objective is changes in pelvis and/or lower limb pain following dorsal
root ganglion (DRG) stimulation. Pain levels will be determined using a 10-point Visual
Analog Scale (VAS) with 10= Extreme Pain and 0= No Pain.
The null hypothesis is there will be no change in the subjects' self-reported pain levels
from baseline to 52 weeks post-stimulator implantation. The alternate hypothesis is a
significant change in pain levels.
Secondary objectives include changes in physical health, quality of life, and pain-related
prescription medication usage. Each subject's overall quality of life will be measured with
the National Institute of Health's PROMIS Global Health survey v1.2. Physical activity
changes will be assessed using the NIH PROMIS Pain Interference 6a SF v1.0 and Pain Intensity
3a scale v1.0. Finally, patients will be asked the name, dosage, and frequency of use of any
pelvic and/or lower limb pain-related prescription medications they are currently using.
Design and Outcomes This is a prospective observational single-arm study to access the
primary outcome variable of pelvic and/or lower limb pain Intervention and Duration There
will be no study intervention. Subjects will only be monitored and evaluated for pre and
post-operative pain, physical activity levels, quality of life, and medication use. Subjects
will be followed for 12 months following their DRG stimulation implant surgery.
Sample Size and Population This study will last for 4 years starting July 1, 2017. There will
be no maximum subject population size. We aim for a minimum population size of 500 in order
to give statistical significance with results. Subjects will be stratified by area of chronic
pain.
root ganglion (DRG) stimulation. Pain levels will be determined using a 10-point Visual
Analog Scale (VAS) with 10= Extreme Pain and 0= No Pain.
The null hypothesis is there will be no change in the subjects' self-reported pain levels
from baseline to 52 weeks post-stimulator implantation. The alternate hypothesis is a
significant change in pain levels.
Secondary objectives include changes in physical health, quality of life, and pain-related
prescription medication usage. Each subject's overall quality of life will be measured with
the National Institute of Health's PROMIS Global Health survey v1.2. Physical activity
changes will be assessed using the NIH PROMIS Pain Interference 6a SF v1.0 and Pain Intensity
3a scale v1.0. Finally, patients will be asked the name, dosage, and frequency of use of any
pelvic and/or lower limb pain-related prescription medications they are currently using.
Design and Outcomes This is a prospective observational single-arm study to access the
primary outcome variable of pelvic and/or lower limb pain Intervention and Duration There
will be no study intervention. Subjects will only be monitored and evaluated for pre and
post-operative pain, physical activity levels, quality of life, and medication use. Subjects
will be followed for 12 months following their DRG stimulation implant surgery.
Sample Size and Population This study will last for 4 years starting July 1, 2017. There will
be no maximum subject population size. We aim for a minimum population size of 500 in order
to give statistical significance with results. Subjects will be stratified by area of chronic
pain.
Inclusion Criteria:
- Prescribed orthopedic surgery or procedure by their healthcare provider.
- Previous conservative care such as physical therapy or chiropractic care that failed
to provide adequate pain relief.
- Willing and able to adhere to the protocol of the study including the survey timeline.
- Between the ages of 18-85 years.
Exclusion Criteria:
- Inability or unwillingness to give written informed consent.
We found this trial at
1
site
Click here to add this to my saved trials
